# A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

> **NCT03198000** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Consumer Inc. (J&JCI)** · enrollment: 120 (actual)

## Conditions studied

- Ophthalmic Solutions

## Interventions

- **DRUG:** F# 13418-148 Eye Drops
- **DRUG:** F#13418-158 Eye Drops
- **DRUG:** F# PF-004390 Eye Drops

## Key facts

- **NCT ID:** NCT03198000
- **Lead sponsor:** Johnson & Johnson Consumer Inc. (J&JCI)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198000, "A Study to Evaluate the Efficacy of Investigational OTC Eye Drops". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03198000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*